AU2001253642A1 - Paclitaxel treatment regimen for metastatic melanoma - Google Patents

Paclitaxel treatment regimen for metastatic melanoma

Info

Publication number
AU2001253642A1
AU2001253642A1 AU2001253642A AU5364201A AU2001253642A1 AU 2001253642 A1 AU2001253642 A1 AU 2001253642A1 AU 2001253642 A AU2001253642 A AU 2001253642A AU 5364201 A AU5364201 A AU 5364201A AU 2001253642 A1 AU2001253642 A1 AU 2001253642A1
Authority
AU
Australia
Prior art keywords
treatment regimen
metastatic melanoma
paclitaxel treatment
paclitaxel
metastatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001253642A
Inventor
Larry Helson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tapestry Pharmaceuticals Inc
Original Assignee
Tapestry Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tapestry Pharmaceuticals Inc filed Critical Tapestry Pharmaceuticals Inc
Publication of AU2001253642A1 publication Critical patent/AU2001253642A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001253642A 2000-04-18 2001-04-18 Paclitaxel treatment regimen for metastatic melanoma Abandoned AU2001253642A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19805500P 2000-04-18 2000-04-18
US60198055 2000-04-18
PCT/US2001/012594 WO2001078710A2 (en) 2000-04-18 2001-04-18 Paclitaxel treatment regimen for metastatic melanoma

Publications (1)

Publication Number Publication Date
AU2001253642A1 true AU2001253642A1 (en) 2001-10-30

Family

ID=22731816

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001253642A Abandoned AU2001253642A1 (en) 2000-04-18 2001-04-18 Paclitaxel treatment regimen for metastatic melanoma

Country Status (3)

Country Link
US (1) US20020013362A1 (en)
AU (1) AU2001253642A1 (en)
WO (1) WO2001078710A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008014953A (en) * 2006-05-26 2009-03-05 Bayer Healthcare Llc Drug combinations with substituted diaryl ureas for the treatment of cancer.
AU2009255357A1 (en) * 2008-05-29 2009-12-10 Bristol-Myers Squibb Company Methods for predicting patient response to modulation of the co-stimulatory pathway

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696153A (en) * 1994-05-16 1997-12-09 Napro Biotherapeutics, Inc. Therapeutic regimen for treating patients

Also Published As

Publication number Publication date
WO2001078710A2 (en) 2001-10-25
US20020013362A1 (en) 2002-01-31
WO2001078710A3 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
PL368945A1 (en) Paclitaxel solvates
AU2001241903A1 (en) Snow-gliding apparatus
GB0029531D0 (en) Speed govenor
AU2001276552A1 (en) Drilling apparatus
AU145624S (en) Wheel
ZA200107824B (en) Apparatus.
AU2001291783A1 (en) Encryption
EP1353184A4 (en) Rotation detector
IL149007A0 (en) Pentacyclic taxane compounds
MXPA03008394A (en) Biurethane derivatives.
EP1333290A4 (en) Rotation detector
AU2001253642A1 (en) Paclitaxel treatment regimen for metastatic melanoma
AU2002215180A1 (en) Beta-lactam antibiotic-polysaccharide complex
SG93926A1 (en) Rotating pile for undergrounding
AU2001278829A1 (en) Nitrogen-potassium fertiliser
AU2001294610A1 (en) Advanced portable integrated colorimeter
AU2001228947A1 (en) Package
AU2001247922A1 (en) Calpain inhibitors in cancer treatment
GB0106472D0 (en) Rotary airer
GB0012225D0 (en) C portal
TW506341U (en) Retaining structure for rotary wheel
AUPQ699600A0 (en) Carrier
AU144418S (en) Wheel
GB0016646D0 (en) Waranlinc wheel
ZA200202040B (en) Taxane prodrugs.